Risk factors and hepatocellular cancer

Nutritional factors and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort.

European journal of clinical nutrition·2015

Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies.

Steroids·2014

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.

British journal of cancer·2014

Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort.

International journal of obesity (2005)·2014

Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1.

Breast cancer research and treatment·2014

Genome-wide meta-analyses of smoking behaviors in African Americans.

Translational psychiatry·2012

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Risk Factors of Incidental Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Cross-Sectional Study with ROC Curve Analysis.

Archives of Iranian medicine·2026

Assessement of Survival and its Affecting Factors in Adult Liver Transplant Patients: A Retrospective Cohort Study.

Archives of Iranian medicine·2026

Beyond Single Biomarkers: A Multidimensional Risk Score for Improved Post-Transplant Prognosis Prediction in Hepatocellular Carcinoma.

Journal of inflammation research·2026

Cumulative high-risk surgical and pathologic features predict recurrence after resection of early-stage node-negative non-small cell lung cancer.

JTCVS open·2026

Reassessing delayed chest closure in lung transplantation: Outcomes from a propensity score-matched cohort.

JTCVS open·2026

Increasing time-to-treatment for resectable non-small cell lung cancer: Predictors and survival impact.

JTCVS open·2026

Related Experiment Videos

Risk factors and hepatocellular cancer

Related Concept Videos

Nutritional factors and non-Hodgkin lymphoma survival in an ethnically diverse population: the Multiethnic Cohort.

Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies.

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium.

Ethnic differences in serum adipokine and C-reactive protein levels: the multiethnic cohort.

Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1.

Genome-wide meta-analyses of smoking behaviors in African Americans.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Risk Factors of Incidental Cholangiocarcinoma in Primary Sclerosing Cholangitis: A Cross-Sectional Study with ROC Curve Analysis.

Assessement of Survival and its Affecting Factors in Adult Liver Transplant Patients: A Retrospective Cohort Study.

Beyond Single Biomarkers: A Multidimensional Risk Score for Improved Post-Transplant Prognosis Prediction in Hepatocellular Carcinoma.

Cumulative high-risk surgical and pathologic features predict recurrence after resection of early-stage node-negative non-small cell lung cancer.

Reassessing delayed chest closure in lung transplantation: Outcomes from a propensity score-matched cohort.

Increasing time-to-treatment for resectable non-small cell lung cancer: Predictors and survival impact.

Related Experiment Videos

Risk factors and hepatocellular cancer

Related Concept Videos

Related Articles